{"companyId":285095,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","ja"],"companyName":"Tiziana Life Sciences Ltd.","headOfficeLocation":"14/15 Conduit Street London, W1S 2XJ United Kingdom","presidentName":"Ivor Elrifi","companySummary":null,"stockCode":"TLSA","currency":"USD","capital":null,"sales":null,"employees":10,"employeesConsolidated":null,"humanCheck":false,"domains":["tizianalifesciences.com"],"businessContents":["Biopharmaceutical drug development","Immunotherapy treatments for neurodegenerative diseases"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://tizianalifesciences.com/","scoreAbout":300,"scoreBusiness":200,"scoreGroup":0,"scoreCustomer":0}]}